FAZIO, GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 10.272
AS - Asia 5.627
EU - Europa 4.455
SA - Sud America 832
AF - Africa 159
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.362
Nazione #
US - Stati Uniti d'America 9.730
SG - Singapore 2.144
CN - Cina 1.223
IT - Italia 1.175
HK - Hong Kong 750
RU - Federazione Russa 641
BR - Brasile 611
VN - Vietnam 551
DE - Germania 542
SE - Svezia 452
CA - Canada 446
IE - Irlanda 412
GB - Regno Unito 234
FR - Francia 211
UA - Ucraina 206
IN - India 190
BD - Bangladesh 139
FI - Finlandia 133
ID - Indonesia 90
TR - Turchia 85
AR - Argentina 82
KR - Corea 71
NL - Olanda 70
IQ - Iraq 66
ES - Italia 59
JP - Giappone 55
AT - Austria 54
MX - Messico 53
ZA - Sudafrica 52
PL - Polonia 50
BE - Belgio 46
DK - Danimarca 40
PH - Filippine 39
SA - Arabia Saudita 39
PK - Pakistan 38
CH - Svizzera 32
EC - Ecuador 32
CO - Colombia 28
VE - Venezuela 28
EG - Egitto 20
UZ - Uzbekistan 19
KE - Kenya 18
AE - Emirati Arabi Uniti 16
GR - Grecia 16
MA - Marocco 16
CL - Cile 14
MY - Malesia 14
CZ - Repubblica Ceca 13
PA - Panama 12
PY - Paraguay 11
ET - Etiopia 10
JO - Giordania 10
LT - Lituania 10
TN - Tunisia 10
AL - Albania 9
AZ - Azerbaigian 9
BO - Bolivia 9
IL - Israele 9
IR - Iran 9
PE - Perù 9
AU - Australia 8
KZ - Kazakistan 8
NP - Nepal 8
BG - Bulgaria 7
CR - Costa Rica 7
OM - Oman 7
DZ - Algeria 6
HU - Ungheria 6
JM - Giamaica 6
RO - Romania 6
AO - Angola 5
BY - Bielorussia 5
PT - Portogallo 5
TW - Taiwan 5
GE - Georgia 4
KG - Kirghizistan 4
NI - Nicaragua 4
NO - Norvegia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BH - Bahrain 3
CI - Costa d'Avorio 3
EE - Estonia 3
EU - Europa 3
KW - Kuwait 3
LB - Libano 3
NG - Nigeria 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BT - Bhutan 2
CG - Congo 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GY - Guiana 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
Totale 21.326
Città #
Ann Arbor 1.479
Singapore 1.303
Ashburn 993
Hong Kong 732
Fairfield 641
San Jose 628
Chandler 490
Woodbridge 482
Dublin 403
Wilmington 336
Toronto 329
Milan 317
Frankfurt am Main 316
Houston 313
New York 261
Seattle 245
Beijing 236
Santa Clara 222
Cambridge 212
Los Angeles 204
Jacksonville 176
Dearborn 168
Ho Chi Minh City 161
Dallas 150
Chicago 148
Hefei 138
Princeton 129
Hanoi 123
The Dalles 123
Shanghai 88
Moscow 85
Lauterbourg 84
Nanjing 83
Buffalo 81
Boardman 69
Seoul 69
Altamura 68
Jakarta 65
São Paulo 65
Helsinki 61
Lawrence 60
Munich 57
Council Bluffs 56
Lissone 53
Orem 49
London 45
San Diego 43
Brussels 42
Montreal 41
Warsaw 40
Denver 39
Tokyo 38
Guangzhou 35
Phoenix 34
Vienna 34
Baghdad 33
Chennai 32
Nuremberg 32
Rome 32
Brooklyn 31
Stockholm 31
Lachine 29
Atlanta 26
Dong Ket 26
Nanchang 25
Poplar 25
Boston 24
Haiphong 24
Hangzhou 24
Johannesburg 24
Memphis 24
Jinan 23
Zurich 23
Ankara 22
Amsterdam 21
Da Nang 21
Monza 21
Turku 21
Lappeenranta 20
Tianjin 20
Paris 19
Rio de Janeiro 19
Salt Lake City 19
Shenyang 19
Andover 18
Brasília 18
San Francisco 18
Changsha 17
Kocaeli 17
Nairobi 17
Sesto San Giovanni 17
Zhengzhou 17
Fremont 16
Tashkent 16
Como 15
Kent 15
New Delhi 14
Querétaro 14
Casalecchio di Reno 13
Dhaka 13
Totale 13.907
Nome #
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 463
NIPBL: a new player in myeloid cells differentiation 447
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 433
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 410
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 408
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 398
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 396
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 379
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 374
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 354
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 342
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 333
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 328
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 328
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 327
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 310
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 307
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 306
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 302
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 301
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 300
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 298
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 295
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 294
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 285
Antibody Deficiency in Patients with Biallelic KARS1 Mutations 274
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 273
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 271
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome 267
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 265
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 261
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 261
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 258
Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies 257
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL 255
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 254
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 252
Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia 250
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 248
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 245
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 245
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 243
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study 241
Cornelia de Lange Syndrome: NIPBL haploinsufficiency downregulates canonical Wnt pathway in zebrafish embryos and patients fibroblasts 240
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 240
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions 240
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia 239
Rings and bricks: Expression of cohesin components is dynamic during development and adult life 228
TEL/ARG induces cytoskeletal abnormalities in 293T cells 221
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7) 211
Williams syndrome and mature B-Leukemia: A random association? 210
The role of PAX5 in ALL 209
La proteina di fusione PAX5/TEL altera l’espressione del BCR, la via di segnale di STAT5 e i processi di adesione e migrazione cellulare: studio in un modello in vitro di leucemia linfoblastica acuta 209
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia 206
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript 205
Characterization of a novel HDAC2 pathogenetic variant: a missing puzzle piece for chromatinopathies 203
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 200
Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia? 200
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia 199
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 199
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis 198
The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease 198
LAL infant introduces a new specific genomic profile 198
Unique genomic profile of infant all patients 197
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 197
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia 195
Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience 193
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 192
Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence 191
Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in GATA2 Deficiency: Case Report 190
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 190
Identical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype 188
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 187
Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects 178
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma 177
Multivariate Analysis Reveals a miRNA Profile Correlated To Karyotype and Outcome In Pediatric B-Cell Precursor ALL 177
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 174
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia 173
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis 171
The recombinome of IKZF1 deletions in B-cell precursor ALL 170
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA 166
Cohesins: Crossroad Between Cornelia de Lange Spectrum and Cancer Predisposition 165
PAX5 and C/EBP α/β tole in atypical non-Langerhans cell histiocytic tumor post Acute Lymphoblastic Leukemia 147
Impairment of Retinoic Acid Signaling in Cornelia de Lange Syndrome Fibroblasts 134
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study 114
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders 108
Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials 100
Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study 91
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE 66
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge 38
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases 12
Totale 21.872
Categoria #
all - tutte 68.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 0 142
2021/20221.040 102 123 111 76 66 83 24 61 60 89 65 180
2022/20231.817 184 601 161 148 73 275 19 115 149 6 62 24
2023/20241.369 48 34 62 95 187 356 251 49 88 39 31 129
2024/20253.528 150 362 250 172 320 121 249 94 366 562 312 570
2025/20268.783 1.031 458 614 1.133 1.091 499 1.232 400 627 819 649 230
Totale 21.872